NEWS & INSIGHTS

The network

Exceptional cancer survival can be found anywhere in the world. Follow our international network of leading oncology centers, clinicians and researchers coming together across countries to identify these rare survivors and help uncover what makes their survival possible.

International oncology network | Rosalind Study

france-oncology-centers-cancer-research

Happy 14 Juillet! French oncology centers are an important part of our oncology network

Liberté, Égalité, Fraternité… and a shared commitment to advance cancer research

world-largest-clinical-oncology-network

New strategic partnerships: our global oncology network continues to expand!

Together, we're building the world's most comprehensive database of exceptional cancer survivors

CHUV-Centre-hospitalier-universitaire-vaudois

CHUV Lausanne received their Rosalind trophy!

Our partnership with CHUV plays a critical role in advancing our Rosalind Study

cure51-servier-paris-saclay-pscc-annual-event

Sharing Insights: our CEO Nicolas Wolikow Speaks at PSCC Annual Event!

Biotech startups and pharmaceutical companies can strengthen partnerships to accelerate drug development

Global-Cancer-Research-Compliance

How Cure51 Builds a Global Cancer Research Project Across 50+ Countries

Running an international oncology network across 50+ countries requires rigorous coordination and strict clinical research compliance

A Strategic Partnership to Rethink Pancreatic Cancer Treatment: Cure51 × CRCM × Institut Paoli-Calmettes

A Strategic Partnership to Rethink Pancreatic Cancer Treatment: Cure51 × CRCM × Institut Paoli-Calmettes

Rosalind-Study-worldwide-oncology-network

Celebrating a huge Rosalind Study milestone: 115+ worldwide partner oncology centers!

Rosalind Study Milestone: 115+ Centers Join Cure51’s International Oncology Network

Simon-Istolainen-Nicolas-Wolikow-Cure51-Exceptional-Cancer-Survivors

Happy New Year 2026! Reflecting on Cure51’s Cancer Research Progress & the Rosalind Study

Happy New Year 2026! Reflecting on Cure51’s Cancer Research Progress & the Rosalind Study

Rosalind Study Launches in Dubai to Advance Cancer Research

Rosalind Study Launches in Dubai in collaboration with Mediclinic Middle East City Hospital and Dr. Shaheenah Dawood to Advance Cancer Research

UNTIL ALL SURVIVE.

From frontline caregivers and patients to researchers and media voices, we bring diverse perspectives together to advance cancer research. Let’s talk.

Contact us

UNTIL ALL SURVIVE.

Rosalind is an independent, proprietary Cure51 clinical study and is not affiliated with any external AI models or products.

©2024 Cure51, All Rights Reserved

©2026 Cure51, All Rights Reserved

Rosalind is an independent, proprietary Cure51 clinical study and is not affiliated with any external AI models or products.

Follow us

Linkedin

Facebook

Instagram

Contact us

Contact us

Follow us

Linkedin

Facebook

Instagram

Contact us

ROSALIND

Contact us